nach oben

Erschienen in:

01.09.2023 | News item

Novartis recalls one lot of Sandimmune due to crystals

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Novartis is voluntarily recalling one lot of Sandimmune Oral Solution (ciclosporin, cyclosporine) in the US due to crystal formation which could potentially result in underdosing or overdosing, according to a company announcement published by the US FDA. …

Novartis Issues Voluntary Nationwide Recall of One Lot of Sandimmune Oral Solution (Cyclosporine Oral Solution, USP), 100 mg/mL Due to Crystallization Internet Document : 11 Sep 2023. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/novartis-issues-voluntary-nationwide-recall-one-lot-sandimmuner-oral-solution-cyclosporine-oral

Titel: Novartis recalls one lot of Sandimmune due to crystals
Publikationsdatum: 01.09.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-46733-0

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Diphenhydramine/lorazepam

Methylprednisolone/mogamulizumab/prednisone

Alemtuzumab/corticosteroids/tacrolimus

Lenvatinib

Multiple drugs

Ribociclib/rosuvastatin